257 related articles for article (PubMed ID: 9037522)
1. Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.
Johnston JA; Norgren S; Ravid R; Wasco W; Winblad B; Lannfelt L; Cowburn RF
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):85-95. PubMed ID: 9037522
[TBL] [Abstract][Full Text] [Related]
2. A new quantitative solution hybridisation-RNase protection assay for APP and APLP2 mRNA.
Johnston JA; Norgren S; Annerén G; Cowburn RF; Lannfelt L
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):77-84. PubMed ID: 9037521
[TBL] [Abstract][Full Text] [Related]
3. Presenilin-1, amyloid precursor protein and amyloid precursor-like protein 2 mRNA levels in human superior frontal cortex during aging.
Flood FM; Cowburn RF; Johnston JA
Neurosci Lett; 1997 Oct; 235(1-2):17-20. PubMed ID: 9389585
[TBL] [Abstract][Full Text] [Related]
4. Quantification of presenilin-1 mRNA in Alzheimer's disease brains.
Johnston JA; Froelich S; Lannfelt L; Cowburn RF
FEBS Lett; 1996 Oct; 394(3):279-84. PubMed ID: 8830658
[TBL] [Abstract][Full Text] [Related]
5. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein gene isoforms in Alzheimer's disease and other neurodegenerative disorders.
Panegyres PK; Zafiris-Toufexis K; Kakulas BA
J Neurol Sci; 2000 Feb; 173(2):81-92. PubMed ID: 10675649
[TBL] [Abstract][Full Text] [Related]
7. APP gene family: unique age-associated changes in splicing of Alzheimer's betaA4-amyloid protein precursor.
Sandbrink R; Masters CL; Beyreuther K
Neurobiol Dis; 1994 Nov; 1(1-2):13-24. PubMed ID: 9216982
[TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein mRNA levels in Alzheimer's disease brain.
Preece P; Virley DJ; Costandi M; Coombes R; Moss SJ; Mudge AW; Jazin E; Cairns NJ
Brain Res Mol Brain Res; 2004 Mar; 122(1):1-9. PubMed ID: 14992810
[TBL] [Abstract][Full Text] [Related]
9. APP gene family. Alternative splicing generates functionally related isoforms.
Sandbrink R; Masters CL; Beyreuther K
Ann N Y Acad Sci; 1996 Jan; 777():281-7. PubMed ID: 8624099
[TBL] [Abstract][Full Text] [Related]
10. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
11. The beta amyloid protein precursor: mRNAs, membrane-associated forms, and soluble derivatives.
Palmert MR; Podlisny MB; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Whitehouse PJ; Witker DS; Oltersdorf T
Prog Clin Biol Res; 1989; 317():971-84. PubMed ID: 2513588
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid precursor protein (APP) and APP-RNA are rapidly affected by glutamate in cultured neurons: selective increase of mRNAs encoding a Kunitz protease inhibitor domain.
Willoughby DA; Rozovsky I; Lo AC; Finch CE
J Mol Neurosci; 1995; 6(4):257-76. PubMed ID: 8860237
[TBL] [Abstract][Full Text] [Related]
13. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
[TBL] [Abstract][Full Text] [Related]
14. Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.
Boix CP; Lopez-Font I; Cuchillo-Ibañez I; Sáez-Valero J
Alzheimers Res Ther; 2020 Aug; 12(1):96. PubMed ID: 32787955
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of amyloid precursor protein and amyloid precursor-like protein 2 during trophic factor withdrawal-induced death of neuronal PC12 cells.
Araki W; Wurtman RJ
Brain Res Mol Brain Res; 1998 May; 56(1-2):169-77. PubMed ID: 9602112
[TBL] [Abstract][Full Text] [Related]
16. Age-related changes in the proportion of amyloid precursor protein mRNAs in Alzheimer's disease and other neurological disorders.
Tanaka S; Liu L; Kimura J; Shiojiri S; Takahashi Y; Kitaguchi N; Nakamura S; Ueda K
Brain Res Mol Brain Res; 1992 Oct; 15(3-4):303-10. PubMed ID: 1331685
[TBL] [Abstract][Full Text] [Related]
17. Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger S; Pietrzik CU
Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
[TBL] [Abstract][Full Text] [Related]
18. Relative increase in Alzheimer's disease of soluble forms of cerebral Abeta amyloid protein precursor containing the Kunitz protease inhibitory domain.
Moir RD; Lynch T; Bush AI; Whyte S; Henry A; Portbury S; Multhaup G; Small DH; Tanzi RE; Beyreuther K; Masters CL
J Biol Chem; 1998 Feb; 273(9):5013-9. PubMed ID: 9478949
[TBL] [Abstract][Full Text] [Related]
19. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease.
Palmert MR; Golde TE; Cohen ML; Kovacs DM; Tanzi RE; Gusella JF; Usiak MF; Younkin LH; Younkin SG
Science; 1988 Aug; 241(4869):1080-4. PubMed ID: 2457949
[TBL] [Abstract][Full Text] [Related]
20. Post-translational processing and turnover kinetics of presynaptically targeted amyloid precursor superfamily proteins in the central nervous system.
Lyckman AW; Confaloni AM; Thinakaran G; Sisodia SS; Moya KL
J Biol Chem; 1998 May; 273(18):11100-6. PubMed ID: 9556595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
